Loading Events


Event Detail

CDC Webinar – Preventing Hospital-Associated Venous Thromboembolism: Practical Strategies That Work

The Division of Blood Disorders (DBD) is proud to announce its “Webinar Series on Blood Disorders.” This webinar series provides evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships.

Dr. Greg Maynard is a hospitalist, Clinical Professor of Medicine, and Chief Quality Officer (CQO) at the University of California, Davis in Sacramento, California. Until recently, he was the Director of the University of California at San Diego Center for Innovation and Improvement Science. Dr. Maynard has led local and regional efforts in preventing venous thromboembolism (VTE), and improving transitions of patient care for the Society of Hospital Medicine (SHM) and several other organizations. He accepted the 2011 National John M. Eisenberg Patient Safety and Quality Award from the National Quality Forum and The Joint Commission for quality improvement efforts on behalf of SHM.

Hospital-associated venous thromboembolism (HA-VTE), which includes deep vein thrombosis (DVT) and pulmonary emboli (PE) occurring after surgery and hospitalization, is a major source of illness, death, and healthcare cost. While some HA-VTE occurs in spite of recommended prevention approaches, there are opportunities to improve VTE prevention at every medical center. In this webinar, Dr. Maynard will discuss key issues and opportunities for reducing HA-VTE, including:

  • Risk factors for VTE and other common “failure modes” that contribute to HA-VTE
  • Proven strategies in reducing HA-VTE
  • Review of commonly used VTE risk assessment models
  • Practical tips to integrate VTE risk assessment and measurement into routine clinical practice

Ordering the correct prophylaxis is only part of the strategy to reduce HA-VTE. Dr. Maynard will also discuss methods to improve adherence to treatment and other prevention approaches, improve patient mobility, and reduce upper extremity DVT.

  • Describe proven prevention strategies in reducing HA-VTE in patients in both medical and surgical settings.
  • List multiple factors contributing to HA-VTE and identify how improvement teams can address factors that can be modified.
  • Identify shortcomings in publicly reported measures for prevention and methods to improve on those measures.
  • Describe proven prevention strategies in reducing HA-VTE in patients in both medical and surgical settings.

This webinar is free and open to public health professionals, clinicians, hospital administrators, and researchers
who desire more information on reducing HA-VTE. Advance registration is required and the number of attendees is limited.

Please preregister with Cynthia Sayers at cay1@cdc.gov or 404-498-0020.